The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood–CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis
Abstract
Peroxynitrite (ONOO − ), a toxic product of the free radicals nitric oxide and superoxide, has been implicated in the pathogenesis of CNS inflammatory diseases, including multiple sclerosis and its animal correlate experimental autoimmune encephalomyelitis (EAE). In this study we have assessed the mode of action of uric acid (UA), a purine metabolite and ONOO − scavenger, in the treatment of EAE. We show that if administered to mice before the onset of clinical EAE, UA interferes with the invasion of inflammatory cells into the CNS and prevents development of the disease. In mice with active EAE, exogenously administered UA penetrates the already compromised blood‐CNS barrier, blocks ONOO − ‐mediated tyrosine nitration and apoptotic cell death in areas of inflammation in spinal cord tissues and promotes recovery of the animals. Moreover, UA treatment suppresses the enhanced blood‐CNS barrier permeability characteristic of EAE. We postulate that UA acts at two levels in EAE: 1 ) by protecting the integrity of the blood‐CNS barrier from ONOO − ‐induced permeability changes such that cell invasion and the resulting pathology is minimized; and 2 ) through a compromised blood‐CNS barrier, by scavenging the ONOO − directly responsible for CNS tissue damage and death.—Hooper, D. C., Scott, G. S., Zborek, A., Mikheeva, T., Kean, R. B., Koprowski, H., Spitsin, S. V. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood–CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. 14, 691–698 (2000)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Peroxynitrite oxidation of sulfhydryls.
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64313-7 · Cited by 2,490
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,194
Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
Ischiropoulos, H., Zhu, L., Chen, J., Tsai, M., Martin, J. C., Smith, C. D., & Beckman, J. S. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90431-u · Cited by 1,495
A Requirement for the Intercellular Messenger Nitric Oxide in Long-Term Potentiation
Schuman, E. M., & Madison, D. V. (1991) · Science · doi:10.1126/science.1720572 · Cited by 1,141
Extensive Nitration of Protein Tyrosines in Human Atherosclerosis Detected by Immunohistochemistry
Beckmann, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., & White, C. R. (1994) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1994.375.2.81 · Cited by 1,123
Asymptomatic hyperuricemia. Risks and consequences in the normative aging study
Campion, E. W., Glynn, R. J., & Delabry, L. O. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90441-4 · Cited by 851
Hooper, D. C., Spitsin, S., Kean, R. B., Champion, J. M., Dickson, G. M., Chaudhry, I., & Koprowski, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.675 · Cited by 569
Self-citationInduction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
Bö, L., Dawson, T. M., Wesselingh, S., Möurk, S., Choi, S., Kong, P. A., Hanley, D., & Trapp, B. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360515 · Cited by 567
Two independent mutational events in the loss of urate oxidase during hominoid evolution
Wu, X., Muzny, D. M., Chi Lee, C., & Thomas Caskey, C. (1992) · Journal of Molecular Evolution · doi:10.1007/bf00163854 · Cited by 535
In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.
Koprowski, H., Zheng, Y. M., Heber-Katz, E., Fraser, N., Rorke, L., Fu, Z. F., Hanlon, C., & Dietzschold, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.3024 · Cited by 474
Self-citationBagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., Tawadros, R., & Koprowski, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12041 · Cited by 456
Self-citationHooper, D. C., Bagasra, O., Marini, J. C., Zborek, A., Ohnishi, S. T., Kean, R., Champion, J. M., Sarker, A. B., Bobroski, L., Farber, J. L., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2528 · Cited by 334
Self-citationSzabÓ, C. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00170-0 · Cited by 251
Apoptosis in the nervous system in experimental allergic encephalomyelitis
Pender, M. P., Nguyen, K. B., McCombe, P. A., & Kerr, J. F. R. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90219-w · Cited by 230
Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier
Wolman, M., Klatzo, I., Chui, E., Wilmes, F., Nishimoto, K., Fujiwara, K., & Spatz, M. (1981) · Acta Neuropathologica · doi:10.1007/bf00691332 · Cited by 223
Peroxynitrite formation within the central nervous system in active multiple sclerosis
Cross, A. H., Manning, P. T., Keeling, R. M., Schmidt, R. E., & Misko, T. P. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00078-2 · Cited by 201
Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis
Waldner, H., Sobel, R. A., Howard, E., & Kuchroo, V. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3100 · Cited by 199
Local nitric oxide production in viral and autoimmune diseases of the central nervous system.
Hooper, D. C., Ohnishi, S. T., Kean, R., Numagami, Y., Dietzschold, B., & Koprowski, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5312 · Cited by 184
Self-citationEvidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis
Claudio, L., Raine, C. S., & Brosnan, C. F. (1995) · Acta Neuropathologica · doi:10.1007/bf00296505 · Cited by 182
Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T., & Sakoda, S. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00114-h · Cited by 176
Uric acid is reduced in the substantia nigra in parkinson's disease: Effect on dopamine oxidation
Church, W. H., & Ward, V. L. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90285-2 · Cited by 173
Whiteman, M., Halliwell, B., & Darley-usmar, V. (1996) · Free Radical Research · doi:10.3109/10715769609149052 · Cited by 168
Biochemistry of Uric Acid and Its Relation to Gout
Seegmiller, J. E., Laster, L., & Howell, R. R. (1963) · New England Journal of Medicine · doi:10.1056/nejm196303282681306 · Cited by 168
Evidence for the production of peroxynitrite in inflammatory CNS demyelination
Cross, A. H., Manning, P. T., Stern, M. K., & Misko, T. P. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00145-8 · Cited by 163
Extensive peroxynitrite activity during progressive stages of central nervous system inflammation
van der Veen, R. C., Hinton, D. R., Incardona, F., & Hofman, F. M. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00013-1 · Cited by 155
Nitric Oxide Synthase in Reactive Astrocytes Adjacent to β-Amyloid Plaques
Wallace, M. N., Geddes, J. G., Farquhar, D. A., & Masson, M. R. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6373 · Cited by 145
BAUER, H., Jung, T., Tsikas, D., Stichtenoth, D. O., Frölich, C., & Neumann, C. R. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00161.x · Cited by 134
Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND
Chou, S. M., Wang, H. S., & Taniguchi, A. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00090-1 · Cited by 118
Similar Functions of Uric Acid and Ascorbate in Man ?
Proctor, P. H. (1970) · Nature · doi:10.1038/228868a0 · Cited by 111
Merrill, J. E., & Murphy, S. P. (1997) · Brain Behavior and Immunity · doi:10.1006/brbi.1997.0496 · Cited by 110
Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutations
Yeldandi, A. V., Yeldandi, V. V., Kumar, S., Murthy, C. V. N., Wang, X., Alvares, K., Rao, M. S., & Reddy, J. K. (1991) · Gene · doi:10.1016/0378-1119(91)90622-i · Cited by 108
Alberati-Giani, D., Malherbe, P., Ricciardi‐Castagnoli, P., Köhler, C., Denis‐Donini, S., & Cesura, A. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.419 · Cited by 101
Tissue specificity and species differences in the distribution of urate oxidase in peroxisomes.
Usuda, N., Mk, R., Hashimoto, T., Rao, M. S. R., & Jk, R. (1988) · PubMed · Cited by 98
Cross, A. H., Keeling, R. M., Goorha, S., San, M., Rodi, C. P., Wyatt, P. S., Manning, P. T., & Misko, T. P. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00147-6 · Cited by 86
Trout, J. J., Koenig, H., Goldstone, A. D., et al. (1986) · PubMed · Cited by 85
Koenig, H., Goldstone, A. D., & Lu, C. Y. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10903.x · Cited by 77
Detection of Nitrosyl Complexes in Human Substantia Nigra, in Relation to Parkinson's Disease
Shergill, J. K., Cammack, R., Cooper, C. E., Cooper, J. A. D., Mann, V. M., & Schapira, A. H. V. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1656 · Cited by 59
Kock, R., Delvoux, B., & Greiling, H. (1993) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1993.31.5.303 · Cited by 50
Conjugated Deferoxamine Reduces Blood-Brain Barrier Disruption in Experimental Optic Neuritis
Guy, J. R., McGorray, S., Qi, X., Fitzsimmons, J. R., Mancuso, A., & Rao, N. A. (2009) · Ophthalmic Research · doi:10.1159/000267494 · Cited by 13
Cited by
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Virág, L., & Szabó, C. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.375 · Cited by 1,373
Structure and function of xanthine oxidoreductase: where are we now?
Harrison, R. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00956-5 · Cited by 790
Oxidative Stress: Relationship with Exercise and Training
Finaud, J., Lac, G., & Filaire, E. (2006) · Sports Medicine · doi:10.2165/00007256-200636040-00004 · Cited by 771
Lotito, S. B., & Frei, B. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.033 · Cited by 770
RetractedA reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713
“However, given the pleiotropic actions of reactive specie”
Background
Metadata
- Authors
- Hooper, D. C., Scott, G. S., Zborek, A., Mikheeva, T., Kean, R. B., Koprowski, H., & Spitsin, S. V.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-04
- Volume
- 14
- Issue
- 5
- Pages
- 691-698
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2119021947
- Cited by
- 390
- References
- 41
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.